Organization profile
Organization profile
The Center for Translational Medicine at the University of Montana is a multidisciplinary hub that advances biomedical discoveries from the lab to real-world applications in health care. The Center supports the development of therapeutics, diagnostics, and technologies with clinical and commercial potential. In addition to driving innovation, the Center promotes education and career development in translational science, biotechnology, and entrepreneurship—preparing students and researchers to navigate and shape the evolving healthcare and biomedical industries.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 6 Clean Water and Sanitation -
SDG 7 Affordable and Clean Energy -
SDG 10 Reduced Inequalities -
SDG 11 Sustainable Cities and Communities -
SDG 12 Responsible Consumption and Production -
SDG 14 Life Below Water -
SDG 16 Peace, Justice and Strong Institutions
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Walid Abdelwahab
- Biomedical and Pharmaceutical Sciences - Research Assistant Professor
- Center for Translational Medicine - Affiliate
Person
-
Philippe Diaz
- Biomedical and Pharmaceutical Sciences - Professor
- Skaggs Institute for Health Innovation - Affiliate
- Center for Structural and Functional Neuroscience - Affiliate
- Center for Translational Medicine - Affiliate
- Montana Biotechnology Center - Affiliate
Person
-
Encapsulation of the lipidated TLR7/8 agonist INI-4001 into ionic liposomes impacts H7 influenza antigen-specific immune responses
Mehradnia, F., Amin, H., Ferrini, M. E., Partlow, H., Borgogna, T., Dachavaram, S. S., T. Ryter, K., Bazin, H. G., Evans, J. T., Burkhart, D. J., DeBuysscher, B. & Abdelwahab, W. M., Feb 2026, In: Drug Delivery and Translational Research. 16, 2, p. 661-674 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
In silico discovery and mechanistic profiling of STING agonists engaging the transmembrane domain
Junaid, A., Pandey, U., Ward, J., Meghani, N., Miller, S., Negron, A., Ryter, K., Burkhart, D., Mizuno, N., DeFilippis, V. R. & Rasheed, O., Jan 5 2026, In: European Journal of Medicinal Chemistry. 301, 118201.Research output: Contribution to journal › Article › peer-review
Open Access -
A novel cationic liposome-formulated toll like receptor (TLR) 7/8 agonist enhances the efficacy of a vaccine against fentanyl toxicity
Hamid, F. A., Le, N. M. N., Song, D., Amin, H., Hicks, L., Bird, S., Siram, K., Hoppe, B., Demeler, B., Evans, J. T., Burkhart, D. J. & Pravetoni, M., Aug 10 2025, In: Journal of Controlled Release. 384, 113901.Research output: Contribution to journal › Article › peer-review
4 Scopus citations